Literature DB >> 17669432

Autologous bone marrow stem cells--properties and advantages.

Claire M Rice1, Neil J Scolding.   

Abstract

The properties of self-renewal and multi-lineage differentiation make stem cells attractive candidates for use in cellular reparative therapy, particularly in neurological diseases where there is a paucity of treatment options. However, clinical trials using foetal material in Parkinson's disease have been disappointing and highlighted problems associated with the use of embryonic stem cells, including ethical issues and practical concerns regarding teratoma formation. Understandably, this has led investigators to explore alternative sources of stem cells for transplantation. The expression of neuroectodermal markers by cells of bone marrow origin focused attention on these adult stem cells. Although early enthusiasm has been tempered by dispute regarding the validity of reports of in vitro (trans)differentiation, the demonstration of functional benefit in animal models of neurological disease is encouraging. Here we will review some of the required properties of stem cells for use in transplantation therapy with specific reference to the development of bone marrow-derived cells as a source of cells for repair in demyelination.

Entities:  

Mesh:

Year:  2007        PMID: 17669432     DOI: 10.1016/j.jns.2007.06.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Adult stem cells and multiple sclerosis.

Authors:  N Scolding
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 2.  Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.

Authors:  Virginie Neirinckx; Cécile Coste; Bernard Rogister; Sabine Wislet-Gendebien
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

Review 3.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

4.  Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cells Int       Date:  2012-05-07       Impact factor: 5.443

5.  Intrathecal Autologous Bone Marrow-Derived Hematopoietic Stem Cell Therapy in Neurological Diseases.

Authors:  M Zakerinia; A Kamgarpour; H Nemati; H R Zare; M Ghasemfar; A R Rezvani; M Karimi; H Nourani Khojasteh; M Dehghani; R Vojdani; S Haghighat; N Namdari; J Rekabpoor; M Tavazo; S Amirghofran; Z Amirghofran; G A Yosefipour; M Ramzi
Journal:  Int J Organ Transplant Med       Date:  2018-11-01

6.  Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration.

Authors:  David Gordon; Gordana Pavlovska; Colin P Glover; James B Uney; David Wraith; Neil J Scolding
Journal:  Neurosci Lett       Date:  2008-10-17       Impact factor: 3.046

Review 7.  Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside.

Authors:  Serhiy Forostyak; Eva Sykova
Journal:  Front Neurosci       Date:  2017-10-24       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.